Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.
Osteoporos Int
; 20(9): 1571-81, 2009 Sep.
Article
en En
| MEDLINE
| ID: mdl-19107385
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Osteoporosis
/
Ácido Etidrónico
/
Alendronato
/
Fracturas Óseas
/
Conservadores de la Densidad Ósea
Tipo de estudio:
Etiology_studies
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Osteoporos Int
Asunto de la revista:
METABOLISMO
/
ORTOPEDIA
Año:
2009
Tipo del documento:
Article